Migraine resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo, M.D.
Overview
Migraine is a neurological disease best known for severe headaches.[1][2][3] Usually, migraine causes episodes of severe or moderate headache (which is often one-sided and pulsating) lasting between several hours to three days, accompanied by gastrointestinal upsets, such as nausea and vomiting, and a heightened sensitivity to bright lights (photophobia) and noise (phonophobia). Approximately one-third of people who experience migraine get a preceding aura.[4] Migraines' secondary characteristics are inconsistent. Triggers precipitating a particular episode of migraine vary widely.[5][6] The efficacy of the simplest treatment, applying warmth or coolness to the affected area of the head, varies between persons, sometimes worsening the migraine.
Causes
- Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- There are no life-threatening causes of migraine, although, migraine should be distinguished from intracranial berry aneurysms ruptures and subarachnoid hemorrhages, which represent real emergencies.
Common Causes
- Allergic reactions
- Bright lights, loud noises, and certain odors or perfumes
- Physical or emotional stress
- Changes in sleep patterns
- Smoking or exposure to smoke
- Skipping meals
- Alcohol
- Caffeine
- Menstrual cycle fluctuations, birth control pills
- Exposure to pesticides (sprayed fruits/vegetables)
- Tension headaches
- Foods containing tyramine (red wine, aged cheese, smoked fish, chicken livers, figs, and some beans), monosodium glutamate (MSG), or nitrates (like bacon, hot dogs, and salami)
- Other foods such as chocolate, nuts, peanut butter, avocado, banana, citrus, onions, dairy products, and fermented or pickled foods.
- Drugs like apremilast, conjugated estrogens, Cidofovir
Management
- Shown below is an algorithm summarizing the treatment of migraine according the American Academy of Neurology guidelines:[7][8][9]
Patient presents with a complaint of headache | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Does patient have new or different headaches in past 6 mo? | Yes | Evaluate red flags • Systemic symptoms: fever, chills, meningismus • Secondary risk factors: malignancy, immunosuppression • Neurologic symptoms or abnormal signs • Onset: sudden/abrupt • Older age >50 years • Pattern change: first headache or different from previous headache history | Yes to any | Appropriate pain management, consultations and admission | Appropriate evaluation for secondary causes | ||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||
1. Are headaches recurrent that interfere with work, family or social function? 2. Do headaches last at least 4 h if untreated? | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes to both questions | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnose migraine | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluate yellow flags • Drug seeking with underlying chronic pain • Recurrent ED visits without appropriate outpatient management/ PCP follow-up or • OARRS report shows opiate use ± multisourcing | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Assess for treatment contraindications: pregnancy, allergies, comorbid conditions | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Avoid opioids | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Treat with Ketorolac 30 mg IVP or 30-60 mg IM + Metoclopramide 10 mg IVP over 2 min or Ondansetron 8 mg IVP + Diphenhydramine 25-50 mg + IVP IV fl uids for hydration | |||||||||||||||||||||||||||||||||||||||||||||||||||||
More than 50% relief? | Yes | Discharge patient 1. Disposition
8. If no PCP, refer to PCP | |||||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Treat with Sumatriptan: 6 mg sc — may repeat in 1 h if no response. (Max dose 12 mg in 24-h period OR DHE-45: Start with 0.25 mg IVP over 1 min or sc. If needed repeat in 1 h 1 mg IVP over 1 min or 1 mg sc. or choose an antiemetic: Prochlorperazine 10 mg IVP over 30 sec q2-4h prn
OR Ondansetron: 4-8 mg IVP over 30 sec | |||||||||||||||||||||||||||||||||||||||||||||||||||||
More than 50% relief? | |||||||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Admit the patient and investigate further | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Be aware of patients who describe a sudden severe thunderclap headache, described as the worst headache of their lives. Perform a non-contrasted CT scan of the head to rule out subarachnoid hemorrhage; if negative, perform a lumbar puncture.[10]
- Distinguish migraine from meningitis if in addition of photophobia and phonophobia, neck stiffness and fever coexist.[9]
- Perform an MRI or CT scan of the head, if intracranial hypertension is suspected. Morning predominant headache accompanied by vomiting supports the diagnosis of intracranial tumors.[11]
Don'ts
- Do not administer Drospirenone and Ethinyl estradiol or Norelgestromin and Ethinyl Estradiol in patients older than 35.[12]
- Do not administer NSAIDs more than 15 days straight do to possible rebound headache.[13]
References
- ↑ "NINDS Migraine Information Page". National Institute of Neurological Disorders and Stroke, National Institutes of Health. Retrieved 2007-06-25.
- ↑ "Advances in Migraine Prophylaxis: Current State of the Art and Future Prospects" (PDF). National Headache Foundation (CME monograph). Retrieved 2007-06-25.
- ↑ "Migraine: diagnosis, management, and new treatment options, Gallagher RM, Cutrer FM, University of Medicine and Dentistry of New Jersey, School of Medicine, Stratford, USA". The American Journal of Managed Care, PMID: 11859906. Retrieved 2007-06-25.
- ↑ "Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache, Jan 2007,British Association for the Study of Headache" (PDF). Retrieved 2007-06-25.
- ↑ Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB (1999). "The inheritance of migraine with aura estimated by means of structural equation modelling". Journal of Medical Genetics. 36 (3): 225–7. PMC 1734315. PMID 10204850. Retrieved 2012-08-30. Unknown parameter
|month=
ignored (help) - ↑ Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB (1999). "The relative role of genetic and environmental factors in migraine without aura". Neurology. 53 (5): 995–9. PMID 10496258. Retrieved 2012-08-30. Unknown parameter
|month=
ignored (help) - ↑ "An Algorithm of Migraine Treatment - touchNEUROLOGY".
- ↑ "www.painmedicinenews.com".
- ↑ 9.0 9.1 "Migraine and Meningitis | JAMA Neurology | JAMA Network".
- ↑ Montemayor ET, Long B, Pfaff JA, Moore GP (August 2018). "Patient with a Subarachnoid Headache". Clin Pract Cases Emerg Med. 2 (3): 193–196. doi:10.5811/cpcem.2018.5.38417. PMC 6075496. PMID 30083630.
- ↑ Sina F, Razmeh S, Habibzadeh N, Zavari A, Nabovvati M (August 2017). "Migraine headache in patients with idiopathic intracranial hypertension". Neurol Int. 9 (3): 7280. doi:10.4081/or.2017.7280. PMC 5641834. PMID 29071043.
- ↑ "Ethinyl estradiol and norelgestromin (transdermal) Uses, Side Effects & Warnings - Drugs.com".
- ↑ Aleksenko D, Maini K, Sánchez-Manso JC. PMID 29262094. Missing or empty
|title=
(help)